chr3-69108943-T-G
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_198271.5(LMOD3):c.*152A>C variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0373 in 637,716 control chromosomes in the GnomAD database, including 1,909 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.036 ( 305 hom., cov: 31)
Exomes 𝑓: 0.038 ( 1604 hom. )
Consequence
LMOD3
NM_198271.5 3_prime_UTR
NM_198271.5 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.235
Genes affected
LMOD3 (HGNC:6649): (leiomodin 3) The protein encoded by this gene is a member of the leiomodin family of proteins. This protein contains three actin-binding domains, a tropomyosin domain, a leucine-rich repeat domain, and a Wiskott-Aldrich syndrome protein homology 2 domain (WH2). Localization of this protein to the pointed ends of thin filaments has been observed, and there is evidence that this protein acts as a catalyst of actin nucleation, and is important to the organization of sarcomeric thin filaments in skeletal muscles. Mutations in this gene have been associated as one cause of Nemaline myopathy, as other genes have also been linked to this disorder. Nemaline myopathy is a disorder characterized by nonprogressive generalized muscle weakness and protein inclusions (nemaline bodies) in skeletal myofibers. Patients with mutations in this gene often present with a severe congenital form of the disorder. [provided by RefSeq, Jan 2015]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.64).
BP6
Variant 3-69108943-T-G is Benign according to our data. Variant chr3-69108943-T-G is described in ClinVar as [Benign]. Clinvar id is 1222613.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.253 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LMOD3 | NM_198271.5 | c.*152A>C | 3_prime_UTR_variant | 3/3 | ENST00000420581.7 | NP_938012.2 | ||
LMOD3 | NM_001304418.3 | c.*152A>C | 3_prime_UTR_variant | 4/4 | NP_001291347.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LMOD3 | ENST00000420581.7 | c.*152A>C | 3_prime_UTR_variant | 3/3 | 1 | NM_198271.5 | ENSP00000414670 | P1 | ||
LMOD3 | ENST00000475434.1 | c.*152A>C | 3_prime_UTR_variant | 4/4 | 5 | ENSP00000418645 | P1 | |||
LMOD3 | ENST00000489031.5 | c.*152A>C | 3_prime_UTR_variant | 4/4 | 2 | ENSP00000417210 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0357 AC: 5435AN: 152160Hom.: 302 Cov.: 31
GnomAD3 genomes
AF:
AC:
5435
AN:
152160
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0378 AC: 18341AN: 485436Hom.: 1604 Cov.: 7 AF XY: 0.0414 AC XY: 10563AN XY: 254956
GnomAD4 exome
AF:
AC:
18341
AN:
485436
Hom.:
Cov.:
7
AF XY:
AC XY:
10563
AN XY:
254956
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0358 AC: 5448AN: 152280Hom.: 305 Cov.: 31 AF XY: 0.0395 AC XY: 2944AN XY: 74452
GnomAD4 genome
AF:
AC:
5448
AN:
152280
Hom.:
Cov.:
31
AF XY:
AC XY:
2944
AN XY:
74452
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
555
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Aug 03, 2018 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at